A new medical innovation controls internal bleeding within minutes.

Recent medical studies and trials have revealed the development of an injectable foam material that could revolutionize the treatment of severe internal bleeding, one of the leading causes of death in cases of accidents and serious injuries.

RevMedx, an American company specializing in the development of bleeding control technologies, announced that it has developed a new foam material, ResQFoam™, designed to treat severe internal bleeding in the abdomen, and reported its successful use in a clinical study.

The new technique involves injecting medical foam into the abdominal cavity, where it expands rapidly to fill the space and compress the bleeding tissues, helping to slow down or temporarily stop the bleeding until surgical intervention can be performed.

Internal bleeding, especially in the abdominal area, is one of the most serious medical conditions, as medical data indicates that a large percentage of those injured may lose their lives even after arriving at the hospital due to the rapid blood loss.

These foam materials work through multiple mechanisms, including creating internal pressure on the source of bleeding, stimulating vasoconstriction and accelerating blood clotting, which contributes to a significant reduction in blood loss.

According to a report published by Business Wire, this substance is injected into the abdominal cavity, where it expands rapidly to generate internal pressure that helps reduce bleeding, giving doctors extra time to move the patient and perform the necessary surgical intervention to treat the underlying cause.

Recent experiments have also shown that some of these foams are capable of self-expanding and adapting to the shape of the injured tissue, and even adhering to it, making them effective even in complex cases where it is difficult to accurately determine the source of bleeding.

In initial clinical trials, this technique helped stabilize the condition of patients who arrived in critical condition after serious accidents, by gaining valuable time before they were taken to the operating room, which could greatly increase their chances of survival.

Despite the promising results, this technology is still in the clinical trial phase and has not yet gained widespread adoption, as doctors warn of potential risks such as infections or side effects, stressing the need for more studies before its use is generalized.

Experts believe that this innovation could represent a “medical breakthrough” in the field of emergency medicine, especially in war zones and major accidents, where time is a crucial factor between life and death.

Dr. Preston Hogley, the lead researcher, explained that the use of the foam helped stabilize the condition of a patient who arrived at the hospital in critical condition following a traffic accident, as his blood pressure and heart rate indicators improved, before he was later discharged from the hospital after his recovery.

Intra-abdominal bleeding is one of the most dangerous types of bleeding, as blood loss occurs internally as a result of injury or disease, making rapid intervention crucial for saving lives.